BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 11559658)

  • 21. [Helicobacter pylori eradication for stage I(E₁) gastric mucosa-associated lymphoid tissue lymphoma: predictive factors of complete remission].
    Kim SJ; Yang S; Min BH; Lee JH; Rhee PL; Rhee JC; Kim JJ
    Korean J Gastroenterol; 2010 Feb; 55(2):94-9. PubMed ID: 20168055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy.
    Alpen B; Thiede C; Wündisch T; Bayerdörffer E; Stolte M; Neubauer A
    Clin Lymphoma; 2001 Sep; 2(2):103-8. PubMed ID: 11707850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
    Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
    Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
    Kuo SH; Cheng AL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.
    Morgner A; Miehlke S; Stolte M; Neubauer A; Alpen B; Thiede C; Klann H; Hierlmeier FX; Ell C; Ehninger G; Bayerdörffer E
    World J Gastroenterol; 2001 Apr; 7(2):248-53. PubMed ID: 11819769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
    Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
    J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
    Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
    Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
    Morgner A; Miehlke S; Fischbach W; Schmitt W; Müller-Hermelink H; Greiner A; Thiede C; Schetelig J; Neubauer A; Stolte M; Ehninger G; Bayerdörffer E
    J Clin Oncol; 2001 Apr; 19(7):2041-8. PubMed ID: 11283137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
    Miki H; Kobayashi S; Harada H; Yamanoi Y; Uraoka T; Sotozono M; Ohmori M
    J Gastroenterol; 2001 Feb; 36(2):121-4. PubMed ID: 11227668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
    J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma.
    Thiede C; Alpen B; Morgner A; Schmidt M; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
    J Clin Oncol; 1998 Dec; 16(12):3822-31. PubMed ID: 9850027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.
    Liu H; Ye H; Ruskone-Fourmestraux A; De Jong D; Pileri S; Thiede C; Lavergne A; Boot H; Caletti G; Wündisch T; Molina T; Taal BG; Elena S; Thomas T; Zinzani PL; Neubauer A; Stolte M; Hamoudi RA; Dogan A; Isaacson PG; Du MQ
    Gastroenterology; 2002 May; 122(5):1286-94. PubMed ID: 11984515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study.
    Montalban C; Santón A; Redondo C; García-Cosio M; Boixeda D; Vazquez-Sequeiros E; Norman F; de Argila CM; Alvarez I; Abraira V; Bellas C
    Ann Oncol; 2005 Sep; 16(9):1539-44. PubMed ID: 15946976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
    Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
    Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.